Avid Bioservices Inc (CDMO)

[entdoc]

hope filled, you are comedic, especially if you rely on me. I have not followed this latest denouement closely, but it does have a certain increased sense of urgency about it, and also credibility. It is easy
to make a case for timing to offset reverse split and/or delisting, but it also seems that PPHM is onto something genuinely positive. That said, I'll say it again: Statistically significant means very little except to the statisticians...especially not to insurance companies. Doctors are largely sheep, easily led, but only by what is considered "standard of care", and "stat-sig" only gets us partway there. If I had any cash now I would probably buy an option or two. I tend to agree with some of the "glass half-empty" crowd here in that if the responding subgroup in the study was significantly large (stat-sig again), the study probably would not have been terminated. I still believe in the anti-phospholipid platform, and believe that it is a worthwhile pursuit to find a fit for Bavi-, or a similar compound. I have difficulty reconciling the marked positive results in lower animals with the mediocre results reported thus far in humans. It must be dose related. We'll see if it cost-effective. Wish I could be more help hope filled!